Osaka Metropolitan University Identifies Novel Streptococcus mobilis sp. nov. in H. pylori-Positive Pre-Neoplastic Stomach

Researchers at Osaka Metropolitan University (OMU) have announced the discovery of a new bacterial species, Streptococcus mobilis sp. nov., isolated from the stomach of a Japanese female patient with Helicobacter pylori-positive pre-neoplastic gastric mucosa. This breakthrough, published in the International Journal of Systematic and Evolutionary Microbiology (IJSEM), sheds light on the complex gastric microbiota associated with conditions leading to gastric cancer, a major health concern in Japan. The strain, designated MT/JULY 2010^T, represents a significant advancement in understanding microbial diversity in diseased stomachs, potentially opening new avenues for research into gastric pathologies.

Helicobacter pylori (H. pylori), a Gram-negative bacterium, infects over half of the global population and is classified as a class I carcinogen by the World Health Organization. In Japan, where gastric cancer remains one of the leading causes of cancer deaths with approximately 50,000 annual fatalities historically, H. pylori infection is implicated in over 90% of cases. Pre-neoplastic changes, such as intestinal metaplasia and atrophy, often precede malignancy, creating an altered microenvironment that fosters diverse bacterial communities.

Isolation Process and Patient Context

The novel bacterium was cultured from a gastric biopsy taken from a patient exhibiting pre-neoplastic mucosal changes alongside active H. pylori infection. Biopsies were processed at OMU's facilities, where the strain grew optimally on standard media under facultative anaerobic conditions. This isolation highlights the challenges of culturing fastidious gastric microbes, requiring specialized techniques developed at the university's labs.

Japan's high H. pylori prevalence, estimated at 30-40% in adults despite eradication efforts, underscores the relevance of such discoveries. Lifetime gastric cancer risk for infected individuals stands at 17% for males and 7.7% for females, emphasizing the need to explore co-occurring microbiota. OMU researchers, led by Professor Shinji Yamasaki, meticulously characterized the isolate, building on prior observations of unidentified coccoid bacteria invading human gastric cells.

Phenotypic Characteristics Defining the Novel Species

S. mobilis sp. nov. is a Gram-positive, non-endospore-forming coccoid bacterium that appears in clusters, chains, pairs, or singly in liquid media. It produces lactic acid, is catalase-negative, and thrives between 20-45°C, pH 5.0-7.0, and 1-4% NaCl. Notably, under phase-contrast microscopy using a hanging drop assay, cells display a distinctive tumbling motion, reminiscent of motility in certain streptococci but rare in gastric isolates.

• Facultative anaerobic growth
• H₂S production and DNase activity
• Numerous fimbriae-like appendages observed via electron microscopy
• Unidentified intracellular structures

These traits distinguish it from close relatives like S. parasanguinis, positioning it as a unique gastric resident potentially adapted to the acidic, H. pylori-dominated niche.

Genomic and Phylogenetic Insights Confirm Novelty

Whole-genome sequencing revealed a DNA G+C content of 41.8 mol% (in silico), closely matching the experimental 42.6 mol%. 16S rRNA gene analysis placed it in a monophyletic cluster with S. parasanguinis ATCC 15912^T, but average nucleotide identity (ANI) was only 94.4%, below the 95-96% species threshold. Digital DNA-DNA hybridization (dDDH) at 58.7% and conventional hybridization at 62.5% further confirmed it as distinct (both <70%).

Phylogenetic trees underscore its placement within the Streptococcus mitis group, known for oral and respiratory associations, yet here adapted to the stomach. Collaboration with Osaka University's Research Institute for Microbial Diseases provided genomic expertise, exemplifying inter-university synergy in Japan.

Osaka Metropolitan University's Role in Infectious Disease Research

OMU's Osaka International Research Center for Infectious Diseases (OIRCD), housed within the Graduate School of Veterinary Science, spearheaded this work. Focused on emerging pathogens, epidemic prediction, and transmission routes, OIRCD integrates multidisciplinary expertise to tackle threats like H. pylori-driven cancers. Professor Yamasaki's team has a track record of novel microbe discoveries, enhancing Japan's leadership in microbiology.

The center's state-of-the-art facilities support culturomics, genomics, and animal models, vital for gastric research. This discovery bolsters OMU's reputation, attracting funding and talent amid Japan's push for advanced life sciences.

Photo by Markus Winkler on Unsplash

H. pylori and Gastric Microbiota Dysbiosis in Japan

H. pylori infection reshapes the gastric microbiome, reducing diversity and enriching genera like Streptococcus, Neisseria, and Rothia. Japanese studies show increased Streptococcus abundance in infected mucosa, correlating with atrophy and metaplasia. Proton pump inhibitors (PPIs), common in Japan for H. pylori therapy, further boost Streptococcus levels independently.

In pre-neoplastic states, this dysbiosis may promote carcinogenesis. S. mobilis's isolation from such tissue suggests it thrives in this altered ecosystem, potentially interacting with H. pylori.

Unique Features: Motility, Invasion, and Appendages

The tumbling motility and fimbriae-like structures hint at adaptive mechanisms for gastric colonization. Prior reports by the OMU team described intracellular and intranuclear invasion by similar coccoids, raising questions about pathogenicity. Electron micrographs reveal novel appendages, possibly aiding adhesion or biofilm formation in mucus layers.

DNase and H₂S production could degrade host DNA or modulate inflammation, features uncommon in oral streptococci but fitting for harsh gastric conditions.

Potential Health Implications and Related Streptococci

While S. mobilis pathogenicity remains unproven, related species like S. anginosus promote gastric inflammation and tumorigenesis via methionine metabolites. Enrichment of Streptococcus in gastric cancer tissues links the genus to progression, possibly exacerbating H. pylori effects. In Japan, where eradication reduces cancer risk by 50-70%, microbiota modulation could enhance prevention.

This find prompts studies on S. mobilis's role in dysbiosis, perhaps as an opportunist in pre-cancerous lesions.

Broader Research Landscape at Japanese Universities

OMU's work aligns with national efforts, including collaborations with Osaka University for genomics. Japanese institutions like University of Tokyo and Kyoto University lead microbiota-gastric cancer research, supported by AMED funding. This discovery contributes to Japan's goal of halving H. pylori-related cancers by 2030 via screening and eradication.

Student involvement in such projects highlights opportunities in veterinary microbiology and infectious diseases at OMU.

Future Directions and Research Opportunities

Upcoming studies may explore S. mobilis's invasiveness, interactions with H. pylori, and prevalence in Japanese cohorts. Animal models could test pro-carcinogenic potential, informing microbiota-targeted therapies.

• Metagenomic surveys of H. pylori-positive stomachs
• In vitro co-culture assays
• Clinical correlations with pre-neoplastic progression

For aspiring researchers, OMU offers positions in infectious diseases, bridging veterinary and human health.Craft your academic CV

Photo by Artyom Korshunov on Unsplash

Conclusion: Advancing Gastric Health Research in Japan

The identification of Streptococcus mobilis sp. nov. by OMU exemplifies Japan's excellence in microbiology, potentially reshaping our view of gastric cancer etiology. As universities like OMU drive innovation, opportunities abound for researchers tackling infectious diseases. Explore Rate My Professor, higher ed jobs, career advice, university jobs, or post a job to join this vital field.